A randomized controlled trial of β-blockers versus endoscopic band ligation for primary prophylaxis: A large sample size is required to show a difference in bleeding rates

Digestive Diseases and Sciences

Volumn 50, Issue 2, 2005, Pages 407-410

  Thuluvath, Paul J ^a,b   Maheshwari, Anurag ^a   Jagannath, Sanjay ^a   Arepally, Aravind ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

blockers; Banding; Cirrhosis; Esophageal varices

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ADULT; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DIGESTIVE TRACT ENDOSCOPY; ENDOSCOPIC BAND LIGATION; ESOPHAGUS VARICES BLEEDING; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INTERMETHOD COMPARISON; LIVER TRANSPLANTATION; MALE; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-ANTAGONISTS; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; HEMOSTASIS, ENDOSCOPIC; HUMANS; LIGATION; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROPRANOLOL;

EID: 12144271585     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-1619-8     Document Type: Article

References (16)

1. Merigan TC, Plotkin GR, Davidson CS: Effect of intravenously administered posterior pituitary extract on hemorrhage from bleeding esophageal varices. N Engl J Med 266:134-135, 1962
2. Conn HO, Ramsby GR, Storer EH, et al.: Intraarterial vasopressin in the treatment of upper gastrointestinal hemorrhage: a prospective, controlled clinical trial. Gastroenterology 68:211-221, 1975
3. Imperiale TF, Carlos Teran J, McCullough AJ: A meta-analysis of somatostatin versus vasopressin in the management of acute esophageal variceal hemorrhage. Gastroenterology 109:1289-1294, 1995
4. D'Amico G, Pietrosi G, Tarantino I, Pagliaro L: Emergency sclerotherapy versus vasoactive drugs for variceal bleeding in cirrhosis: A Cochrane meta-analysis. Gastroenterology 124:127-191, 2003
5. Thuluvath PH, Krishnan A: Primary prophylaxis of variceal bleeding. Gastrointest Endosc 58:558-567, 2003
6. Groszmann RJ, Bosch J, Grace ND, et al.: Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology 99:1401-1407, 1990
7. Beppu K, Inokuchi K, Koyanagi N, Nakayama S, Sakata H, Kitano S, Kobayashi M: Prediction of variceal hemorrhage by esophageal endoscopy. Gastrointest Endosc 27:213-218, 1981
8. D'Amico G, Pagliaro L, Bosch J: The treatment of portal hypertension: A meta-analytic review. Hepatology 22:332-354, 1995
9. Pascal JP, Cales P: Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 317:856-861, 1987
10. Poynard T, Cales P, Pasta L, Ideo G, Pascal JP, Pagliaro L, Lebrec D: Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group. N Engl J Med 324:1532-1538, 1991
11. Hayes PC, Davis JM, Lewis JA, Bouchier IA: Meta-analysis of value of propranolol in prevention of variceal haemorrhage. Lancet 336:153-156, 1990
12. Sarin SK, Lamba GS, Kumar M, Misra A, Murthy NS: Comparison of endoscopic ligation and propranolol for the primary prevention of variceal bleeding. N Engl J Med 340:988-993, 1999
13. Lui HF, Stanley AJ, Forrest EH, et al.: Primary prophylaxis of variceal hemorrhage: A randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology 123:735-744, 2002
14. De BK, Ghoshal UC, Das T, Santra A, Biswas PK: Endoscopic variceal ligation for primary prophylaxis of esophageal variceal bleed: Preliminary report of a randomized controlled trial. J Gastroenterol Hepatol 14:220-224, 1999
15. Merkel C, Sacerdoti D, Bolognesi M, et al.: Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the beta-blocker alone. Hepatology 26:34-39, 1997
16. Hicken BL, Sharara AI, Abrams GA, Eloubeidi M, Fallon MB, Arguedas MR: Hepatic venous pressure gradient measurements to assess response to primary prophylaxis in patients with cirrhosis: a decision analytical study. Aliment Pharmacol Ther 17:145-153, 2003